TrialBioMed research international2020

Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study.

Yuqiong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.